Lipoproteid subfractions in patients with various cardiovascular risk

Authors

  • E. A. Utkina
  • N. V. Artemieva
  • M. V. Ezhov
  • O. I. Afanasieva
  • S. N. Pokrovsky

DOI:

https://doi.org/10.34687/2219-8202.JAD.2022.01.0006

Abstract

Aim. To analyze lipoproteins subfractions in subjects with various cardiovascular risk and cardiovascular disease (CVD).
Materials and methods. We included 91 patients (66 men, mean age 57±10 years; 25 women, mean age 61±11 years) with one or more atherosclerosis risk factors, with and without CVD. All patients were on hy- polipidemic therapy with statins. Lipid parameters were determined by the enzymatic method, the quanti- tative determination of lipoprotein subfractions was carried out using the Lipoprint® Quantimetrix system (USA).
Results. All patients were divided into three groups: moderate risk (group 1, n = 13), high risk (group 2, n = 12), and very high risk with CVD (group 3, n = 66). Tere were no statistically significant differences between the groups in lipids and lipoproteins subfractions, excepting small dense low-density lipoprotein
(sdLDL) particles in the group 1 and 3 (median [25%; 75%]: 0.0 [0.0; 2.0] mg/dL and 2.0 [0.0; 3.0] mg/dL, respectively, p < 0.05). We found that cardiovascular risk was positively associated with age (r = 0.325; p <0.01), the levels of subfractions of intermediate-density lipoproteins (IDL-C, r = 0.225; p = 0.032) and sdLDL (r = 0.216; p < 0.039). An inverse relationship was demonstrated with small subfractions of IDL (IDL-A, r = -0.210; p = 0.046). According to multivariate analysis only association of sdLDL with higher cardiovascular risk remained (p = 0.022).
Conclusion. Patients with high and very high cardiovascular risk have increased levels of sdLDL particles.

Downloads

Download data is not yet available.

Published

2022-05-26

How to Cite

Utkina E. A., Artemieva N. V., Ezhov M. V., Afanasieva O. I., Pokrovsky S. N. Lipoproteid subfractions in patients with various cardiovascular risk // The Journal of Atherosclerosis and Dyslipidemias. 2022. VOL. № 1 (46). PP. 57–63.

Issue

Section

Original research paper